Status:
COMPLETED
GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL
Lead Sponsor:
Dr. Anatoly Langer
Collaborating Sponsors:
Amgen
Conditions:
Dyslipidemia
Eligibility:
All Genders
18+ years
Brief Summary
This Quality Enhancement Research Initiative (QuERI) is a knowledge translation medical practice activity based on decision making support through feedback to physicians on their management of dyslipi...
Detailed Description
The GOAL QuERI International will engage approximately 115 health care practitioners (HCP) who will enroll up to 2500 patients with management observations based on four visits by the patients in an o...
Eligibility Criteria
Inclusion
- Adults ≥ 18 years old
- High risk for cardiovascular morbidity and mortality such as prior history of clinical cardiovascular disease and/or history of familial hypercholesterolemia
- LDL-C within the past 6 months above recommended level despite maximal tolerated statin therapy ± ezetimibe for the past 3 months.
Exclusion
- Current treatment with PCSK9 inhibitor
- Current participation in investigational study
- Prior participation in the GOAL program
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
2422 Patients enrolled
Trial Details
Trial ID
NCT03861533
Start Date
April 1 2019
End Date
December 31 2022
Last Update
August 22 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Sabah Hosptial
Kuwait City, Kuwait
2
Centro de Estudios Clínicos de Querétaro (CECLIQ)
Querétaro City, Querétaro, Mexico
3
King Fahd Military Medical Complex
Dhahran, Saudi Arabia, 31932
4
Cleveland Clinic
Abu Dhabi, United Arab Emirates